Pliant Therapeutics earnings were -$210.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PLRX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$49.7M, down 13.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PLRX reported annual earnings of -$210.3M, with 30.4% growth. The next PLRX earnings date is May 5, 2025.
Pliant Therapeutics Earnings Reports & History FAQ
What were Pliant Therapeutics's earnings last quarter?
On PLRX's earnings call on Invalid Date, Pliant Therapeutics (NASDAQ: PLRX) reported Q4 2024 earnings per share (EPS) of -$0.81, up 17.39% year over year. Total PLRX earnings for the quarter were -$49.73 million. In the same quarter last year, Pliant Therapeutics's earnings per share (EPS) was -$0.69.
The next PLRX earnings date is Invalid Date. Add PLRX to your watchlist to be reminded of Pliant Therapeutics's next earnings date.
What was PLRX's earnings growth in the past year?
As of Pliant Therapeutics's earnings date in Invalid Date, Pliant Therapeutics's earnings has grown year over year. PLRX earnings in the past year totalled -$210.30 million.
Is Pliant Therapeutics profitable or losing money?
As of the last Pliant Therapeutics earnings report, Pliant Therapeutics is currently losing money. Pliant Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$210.30 million, a 30.35% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.